The company will build on research carried out by London artificial intelligence lab DeepMind, which Google acquired in 2014. Demis Hassabis, the CEO and co-founder of DeepMind, is the founder and CEO ...
Isomorphic Labs, Google’s artificial intelligence drug business, raised $600 million in its first external funding round, the company said on Monday. Thrive Capital, a venture capital firm, led the ...
Isomorphic Labs Inc., a healthcare startup that spun out of Alphabet Inc. in 2021, today announced that it has closed a $600 million funding round. OpenAI backer Thrive Capital led the investment. It ...
This guest post comes courtesy of Jason Bloomberg, managing partner atZapThink. Take the BriefingsDirect middleware/ESB survey now. On the other hand, there are plenty of enterprise architects who do ...
Last year, Alphabet’s DeepMind announced its AlphaFold 2 AI showed it could predict how certain proteins would fold in a way that was competitive with experimental data. The news was met with ...
Update: The story was updated with Isomorphic declining to comment. Google's DeepMind spinoff Isomorphic Labs expects clinical trial of drugs it designed using AI to start this year, Bloomberg News ...
LONDON--(BUSINESS WIRE)--Isomorphic Labs, a subsidiary of Alphabet, today announced the first phase of its management team. The company, established in November, was launched from Alphabet’s DeepMind ...
AI research wunderkind, DeepMind, has long been all fun and games. The London-based organization, owned by Google parent company Alphabet, has used deep learning to train algorithms that can take down ...
MASTERING HEALTHCARE MANAGEMENT JUST IN 7 DAYS: Command HR Leadership And Scalable Strategies To Ensure Your Hospital Runs Smoothly Without You Isomorphic Labs, a drug discovery company spun out of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results